Navigation Links
Cell Proliferation Assay Using the Benchmark Plus Microplate Spectrophotometer

William C Heiser, PhD and Ma Theresa Redila-Flores, Bio-Rad Laboratories, Inc . , Hercules, CA 94547 USA


Introduction
An accurate and rapid assessment of viable cell number and proliferation is often required for in vitro and in vivo experiments. These assessments are necessary and useful for analysis of growth factor activity, drug screening, serum batch testing, and toxicological determination of carcinogenic compounds, to name a few. Cell proliferation kits are used to measure cell viability and division in response to growth factors, cytokines, and nutrients, as well as growth inhibition by cytotoxic agents. The cell proliferation kit described here utilizes a microplate spectrophotometer to quantitate an assay based on XTT, a tetrazolium salt that is cleaved as a result of metabolic activity to generate a colored formazan product.


Method
A cell proliferation kit from Roche was used to measure proliferation of A549 cells grown at different densities overnight. The cells were incubated with XTT before measuring the absorbance. To confirm the optimal wavelength at which to read the samples, a spectral scan was done. The cells were then read after 1, 2, and 3 hr of incubation as suggested in the kit instructions.

Procedure
1. Inoculate A549 cells into a 25 cm2 flask with DMEM or appropriate medium. Grow cells to 70% confluence.

2. Wash cells with 1x PBS. Trypsinize, then add 2 ml of appropriate medium.

3. Dilute cells 10-fold, to about 2.5 x 105 cells/ml. Prepare 2-fold dilutions and plate 100 l of each dilution in replicates of 5 in a 96-well plate. Prepare a blank by dispensing medium without cells in replicates of 5. Swirl the plate to evenly distribute cells in the wells. Incubate plate overnight at 37C.

4. Prepare XTT labeling mix according to instructions and add 50 l to each well. Incubate at 37C for 1, 2, and 3 hr.

5. After 1 hr of incubation, place the plate into the Benchmark Plus.

6. To determine the optimum wavelength for the assay, run a spectral scan. In Microplate Manager PC software, select File>New Endpoint Protocol>Advanced Options>Scan Well. Scan three wells with different cell densities a cross the wavelength range 340800 nm with a step size of 5 nm. Next, construct a graph to show the peak wavelength around 475 nm (the re commended wavelength for reading the assay) for all samples scanned.

7. After the spectral scan, open the Microplate Manager software application. Under the File menu, select New Endpoint Protocol. Next, select the 96-well format and edit the template, selecting the wells used. Specify a single-wavelength reading at the peak wavelength determined in step 6.

8. Assay the plate using the Benchmark Plus by clicking the Run button. Repeat for the 2 and 3 hr incubation times.

9. After reading the samples, export or copy and paste the data points into Microsoft Excel software and plot them.


Results
Figure 1 shows the results obtained by scanning sample wells with different cell densities (step 6 of Procedure). The scan resulted in an absorbance curve that peaked at about 475 nm, the wavelength specified for sample reading in the XTT kit instructions.

The assay was performed at 475 nm. Figure 2 shows a proportional increase in the OD value at 475 nm with increasing cell number.


Conclusion
The measurement of cell viability and cell division is used in a wide range of experiments to determine growth factor activity, for drug screening, and to determine the effects of chemical transfectants on human cells. We tested the Roche cell proliferation kit for measurement of cell density of A549 cells grown in 96-well plates. After 24 hr, when the cells were ~90% confluent in the wells with the most cells, we performed the cell proliferation assay.

At low cell density (cells ~50% confluent on the plate), there was a proportional increase in OD 475 with increasing cell number. At high cell density, the increase in OD 475 was not proportional to the increase in cell number. As seen in the figure, this increase was independent of the length of incubation with the reagent between 1 and 3 hr. However, at shorter incubation times (0.5 hr, data not shown), the OD 475 was proportional to cell number up to 5070% confluence.


Bibliography
Guide to Cell Proliferation and Apoptosis Methods, Roche Applied Science, available online at http://www.roche-applied-science.com/fst/publications.htm?/ prod_inf/manuals/cell_man/cell_toc.html

Roehm NW et al., An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT, J Immunol Methods 142, 257265 (1991)


back to top
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Cell Proliferation Kit Outperforms the Competition in the Range of Cells Typically Counted
2. Quantitative Measurement of Cell Proliferation Using the BrdU ELISA: A Comparison Between Colorimetric and Chemiluminescent Detection
3. Cell Proliferation and Viability Measurement
4. measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay
5. Identification of cells in S phase using the Cell Proliferation Fluorescence Kit and IN Cell Analyzer 1000
6. Cell Proliferation Assays
7. A Positive Selection Assay for Mutation Analysis in Big Blue Animals
8. Luminol-enhanced Assay for Superoxide Anion (O2 face="Symbol" )
9. Organize Your Data from the Big Blue Mutation Assay
10. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
11. RNase Protection Assay (RPA) Using DIG-Labeled RNA Probes

Post Your Comments:
(Date:11/24/2009)... , SANTA CRUZ, Calif., Nov. 24 /PRNewswire/ ...io Career Center, the nation,s leading online job ...als. ,, Northwestern and Columbia University ar...ajor life science training Institutions. ,, The... post-graduates in the life sciences. While there ...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November.... (Nasdaq: DCGN ) today announced that it has rece...ing in the company,s common stock will be,suspende...e filed with the,Securities and Exchange Commissio...sting on Nasdaq, unless the company files an appea...
(Date:11/24/2009)... Health care employment grew b...e only one to show consistent growth during the U....tals remain in trouble, and health systems are com...nnel, instead of just administrators. , ... care employment continued growing in October desp...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ --...& Trademark Office (PTO) has allowed the paten...or NOD technology. , NOD technology is a ...or,proteins into bio-adhesive nano-particles to en... as injections. NOD technology is a platform techn...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
... 26 Joseph F. Finn, Jr., C.P.A. ("Finn"), announc...erest from pharma companies in the intellectual pr.... , , In preclinical studies, GCS-100 inhibited b...s. Development and growth of solid tumors require...iver oxygen and nutrients to a tumor. Galectin-3 ...
...outstanding, world-changing leaders to participate...s of the TED Conference introduced today the 25 ne... international conference, TEDGlobal. These Fellow...ttending TEDGlobal 2009, to be held in Oxford, UK,...TED Fellows selected for the TED2009 Conference, h...
...ornia and AMSTERDAM, May 26 ,Agendia, a world lead...d the,opening of its U.S. clinical genomics labora...lly-licensed and compliant with the Clinical Labor...ed by the Centers for Medicare,and Medicaid Servic...ncer genomics laboratory, Agendia has,over the pas...
Other Biology Technology:Prospect Therapeutics, Inc.'s GCS-100 Inhibited Blood Vessel Formation in a Variety of Cancer Models 2TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford 2TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford 3TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford 4TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford 5Agendia Opens CLIA-Registered U.S. Genomics Laboratory 2Agendia Opens CLIA-Registered U.S. Genomics Laboratory 3
(Date:11/25/2009)...Head of the Cell Death Research Laboratory in the ...een awarded the prestigious Johnson & Johnson Focu...ause of brain cell damage in Parkinson,s disease. ...s in support of innovation and excellence in scien...d earlier this month at an event at the Hyatt Rege...
(Date:11/24/2009)...s it has been prescribed by traditional healers in...s and stomach pain to fever and flu. , Now for th...have been able to scientifically prove the pain re...known as Brazilian mint. , Testing this ancient S...cher Graciela Rocha was able to show that when pre...
(Date:11/24/2009)...on of a remarkable class of ring-shaped protein mo...wrence Berkeley National Laboratory (Berkeley Lab)...beamline at the Advanced Light Source (ALS). These...ion and replication, and are vital to the survival...ents, such as the human papillomavirus, which has ...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 1Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 2Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 3Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 4Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 5Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 6Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 7Cancer Diagnostics Company On Q ity Raises 2421M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 5961 1Cancer Diagnostics Company On Q ity Raises 2421M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 5961 2Varian Inc to Release Fourth Quarter and Full Fiscal Year 2009 Financial Results 5957 1
...searchers at NYU Langone Medical Center may have d...ndrome (BTHS). BTHS, a sometimes fatal disease, is...y in males that leads to infection or heart failur...alcium-independent phospholipase A2 in the pathoge...n the Proceedings of the National Academy of Scie...
...N ARBOR, Mich. Researchers from the University of...ied a gene that is overexpressed in 90 percent of .... , Expression of the gene, Ataxia Telangiectasia...erage 20 times higher in pancreatic cancer cells t...the gene appears to make pancreatic cancer cells r...
... international team of scientists, led by Monash U...of a superbug that kills elderly hospital patients... save lives and health care systems billions of do...n the prestigious scientific journal Nature , unr...Clostridium difficile and solved the mystery surr...
Other Biology News:New potential therapeutic target discovered for genetic disorder -- Barth syndrome 2U-M researchers ID gene involved in pancreatic cancer 2Monash scientists debug superbug 2
... fluorescent nucleic acid dye which binds only to ...erstain, propidium iodide stains the nucleus light...provides excellent contrast to green or blue fluor...ide can be used for fluorescent in situ hybridizat...
...ter assay for mitochondrial membrane potential det...are detected by carboxyfluorescein (FAM)-labelled ... are cell-permeable, non-cytotoxic and bind covale...he same time the mitochondrial membrane potential ...
...tured in DMEM and harvested at the log phase of gr...ve forms, cells were fixed in acetone-methanol. T...coated slide, with each wells surface specifically...imize background staining. Each well is loaded wi...
...r can be induced prior to DNA purification increas...y of single-copy BACs with the high yields associa...s provide the linearized vector and associated rea...stem) necessary to create a 10X human BAC library....
Biology Products: